Justin Walsh
Stock Analyst at JonesTrading
(4.61)
# 940
Out of 5,118 analysts
400
Total ratings
35.2%
Success rate
14.3%
Average return
Main Sectors:
Stocks Rated by Justin Walsh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SPTX Seaport Therapeutics | Reiterated: Buy | $32 | $21.50 | +48.84% | 4 | Nov 2, 2026 | |
| CATX Perspective Therapeutics | Reiterated: Buy | $18 → $6 | $0.84 | +614.29% | 36 | Oct 28, 2026 | |
| ATNM Actinium Pharmaceuticals | Reiterated: Buy | $3 | $1.43 | +109.79% | 34 | Oct 21, 2026 | |
| RAPP Rapport Therapeutics | Reiterated: Buy | $50 → $82 | $24.44 | +235.52% | 23 | Oct 21, 2026 | |
| PRAX Praxis Precision Medicines | Reiterated: Buy | $441 → $534 | $277.62 | +92.35% | 13 | Oct 1, 2026 | |
| DFTX Definium Therapeutics | Reiterated: Buy | $90 | $33.27 | +170.51% | 9 | Sep 15, 2026 | |
| RNXT RenovoRx | Reiterated: Buy | $8 | $1.13 | +607.96% | 6 | Aug 19, 2026 | |
| CLNN Clene | Reiterated: Buy | $30 | $3.95 | +659.49% | 15 | Aug 18, 2026 | |
| NMTC NeuroOne Medical Technologies | Reiterated: Buy | $8 | $0.879 | +810.13% | 4 | Aug 18, 2026 | |
| SER Serina Therapeutics | Reiterated: Buy | $11 | $1.38 | +697.10% | 9 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $100.61 | - | 32 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $3.25 | +238.46% | 15 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.71 | - | 11 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.16 | - | 12 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $25.16 | +74.88% | 19 | Jun 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $24 | $0.1959 | +12,151.15% | 5 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $6.72 | +197.62% | 23 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $0.9588 | +3,028.91% | 7 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $19.88 | - | 27 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $71.42 | n/a | 7 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.6427 | n/a | 16 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.40 | $0.00 | n/a | 6 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $4.65 | n/a | 6 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $4 | $0.7141 | n/a | 9 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.9065 | n/a | 12 | Jun 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $4.42 | n/a | 15 | May 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $20 | $26.89 | n/a | 2 | May 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.7588 | n/a | 4 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $6 | $4.80 | n/a | 3 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $56.46 | n/a | 2 | Apr 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 | $0.000001 | n/a | 2 | Jan 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.32 | n/a | 2 | Nov 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.47 | n/a | 3 | Nov 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $9.54 | n/a | 5 | Nov 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $40 | $3.00 | n/a | 1 | Sep 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $0.9898 | n/a | 1 | Feb 17, 2021 |
Seaport Therapeutics
Nov 2, 2026
Reiterated: Buy
Price Target: $32
Current: $21.50
Upside: +48.84%
Perspective Therapeutics
Oct 28, 2026
Reiterated: Buy
Price Target: $18 → $6
Current: $0.84
Upside: +614.29%
Actinium Pharmaceuticals
Oct 21, 2026
Reiterated: Buy
Price Target: $3
Current: $1.43
Upside: +109.79%
Rapport Therapeutics
Oct 21, 2026
Reiterated: Buy
Price Target: $50 → $82
Current: $24.44
Upside: +235.52%
Praxis Precision Medicines
Oct 1, 2026
Reiterated: Buy
Price Target: $441 → $534
Current: $277.62
Upside: +92.35%
Definium Therapeutics
Sep 15, 2026
Reiterated: Buy
Price Target: $90
Current: $33.27
Upside: +170.51%
RenovoRx
Aug 19, 2026
Reiterated: Buy
Price Target: $8
Current: $1.13
Upside: +607.96%
Clene
Aug 18, 2026
Reiterated: Buy
Price Target: $30
Current: $3.95
Upside: +659.49%
NeuroOne Medical Technologies
Aug 18, 2026
Reiterated: Buy
Price Target: $8
Current: $0.879
Upside: +810.13%
Serina Therapeutics
Aug 18, 2026
Reiterated: Buy
Price Target: $11
Current: $1.38
Upside: +697.10%
Aug 14, 2026
Reiterated: Hold
Price Target: n/a
Current: $100.61
Upside: -
Aug 10, 2026
Reiterated: Buy
Price Target: $11
Current: $3.25
Upside: +238.46%
Jul 31, 2026
Rated: Hold
Price Target: n/a
Current: $1.71
Upside: -
Jul 31, 2026
Rated: Hold
Price Target: n/a
Current: $2.16
Upside: -
Jun 26, 2026
Reiterated: Buy
Price Target: $44
Current: $25.16
Upside: +74.88%
May 18, 2026
Reiterated: Buy
Price Target: $60 → $24
Current: $0.1959
Upside: +12,151.15%
May 12, 2026
Reiterated: Buy
Price Target: $20
Current: $6.72
Upside: +197.62%
Mar 25, 2026
Reiterated: Buy
Price Target: $30
Current: $0.9588
Upside: +3,028.91%
Jan 5, 2026
Rated: Hold
Price Target: n/a
Current: $19.88
Upside: -
May 14, 2025
Reiterated: Hold
Price Target: n/a
Current: $71.42
Upside: n/a
Mar 21, 2025
Rated: Hold
Price Target: n/a
Current: $0.6427
Upside: n/a
Oct 30, 2024
Reiterated: Buy
Price Target: $0.40
Current: $0.00
Upside: n/a
Aug 8, 2024
Reiterated: Buy
Price Target: $20
Current: $4.65
Upside: n/a
Jun 4, 2024
Reiterated: Buy
Price Target: $8 → $4
Current: $0.7141
Upside: n/a
Jun 6, 2022
Reiterated: Buy
Price Target: $10
Current: $0.9065
Upside: n/a
May 19, 2022
Reiterated: Buy
Price Target: $18
Current: $4.42
Upside: n/a
May 19, 2022
Reiterated: Buy
Price Target: $16 → $20
Current: $26.89
Upside: n/a
May 10, 2022
Reiterated: Buy
Price Target: $10
Current: $0.7588
Upside: n/a
May 4, 2022
Reiterated: Buy
Price Target: $7 → $6
Current: $4.80
Upside: n/a
Apr 7, 2022
Reiterated: Buy
Price Target: $10
Current: $56.46
Upside: n/a
Jan 11, 2022
Upgraded: Buy
Price Target: $7
Current: $0.000001
Upside: n/a
Nov 26, 2021
Rated: Hold
Price Target: n/a
Current: $3.32
Upside: n/a
Nov 26, 2021
Rated: Hold
Price Target: n/a
Current: $4.47
Upside: n/a
Nov 17, 2021
Reiterated: Buy
Price Target: $30
Current: $9.54
Upside: n/a
Sep 2, 2021
Initiated Coverage: Buy
Price Target: $40
Current: $3.00
Upside: n/a
Feb 17, 2021
Initiated Coverage: Buy
Price Target: $4
Current: $0.9898
Upside: n/a